Pfizer Wins Dismissal Of Securities Suit Over Drug
Pfizer's knowledge that evidence of torcetrapib’s efficacy was inconclusive did not support an inference that its optimistic statements were materially misleading, Judge Lewis A. Kaplan of the U.S. District Court for the Southern District of New York said Thursday.
“Defendants were entitled to take an optimistic...
Already a subscriber? Click here to login